Your browser doesn't support javascript.
loading
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients.
Thana, Myuran; Basappa, Naveen S; Ghosh, Sunita; Kollmannsberger, Christian K; Heng, Daniel Y C; Hansen, Aaron R; Graham, Jeffery; Soulières, Denis; Reaume, Martin Neil; Lalani, Aly-Khan A; Castonguay, Vincent; Bjarnason, Georg A; Patenaude, François; Breau, Rodney H; Pouliot, Frédéric; Kapoor, Anil; Wood, Lori A.
Afiliación
  • Thana M; Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. Electronic address: myuran.thana@nshealth.ca.
  • Basappa NS; Division of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Ghosh S; Division of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Kollmannsberger CK; Division of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada.
  • Heng DYC; Department of Medical Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Hansen AR; Department of Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Graham J; CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Soulières D; Division of Medical Oncology/Hematology, Le Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Reaume MN; Division of Medical Oncology, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, Ontario, Canada.
  • Lalani AA; Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada.
  • Castonguay V; Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Québec, Canada.
  • Bjarnason GA; Division of Medical Oncology/Hematology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Patenaude F; Department of Medicine, Hematology Service and Department of Oncology, Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montréal, Québec, Canada.
  • Breau RH; Division of Urology, Department of Surgery, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Pouliot F; Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Québec, Canada.
  • Kapoor A; Division of Urology, McMaster University, Hamilton, Ontario, Canada.
  • Wood LA; Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Clin Genitourin Cancer ; 20(3): 210-218, 2022 06.
Article en En | MEDLINE | ID: mdl-35115252
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article